157 related articles for article (PubMed ID: 28772226)
21. Laser diode thermal desorption atmospheric pressure chemical ionization tandem mass spectrometry applied for the ultra-fast quantitative analysis of BKM120 in human plasma.
Lanshoeft C; Heudi O; Leuthold LA; Schlotterbeck G; Elbast W; Picard F; Kretz O
Anal Bioanal Chem; 2014 Sep; 406(22):5413-23. PubMed ID: 24958346
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous determination of a novel oral Janus kinase inhibitor ASP015K and its sulfated metabolite in rat plasma using LC-MS/MS.
Oda K; Mera K; Nagasaka Y; Tokoro K
Biomed Chromatogr; 2015 Jul; 29(7):967-9. PubMed ID: 25380383
[TBL] [Abstract][Full Text] [Related]
23. Liquid chromatography-tandem mass spectrometry assay for the EGFR inhibitor pelitinib in plasma.
Luethi D; Durmus S; Schinkel AH; Schellens JH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Sep; 934():22-5. PubMed ID: 23892825
[TBL] [Abstract][Full Text] [Related]
24. A strategy for extending the applicability of a validated plasma calibration curve to quantitative measurements in multiple tissue homogenate samples: a case study from a rat tissue distribution study of JI-101, a triple kinase inhibitor.
Gurav SD; Jeniffer S; Punde R; Gilibili RR; Giri S; Srinivas NR; Mullangi R
Biomed Chromatogr; 2012 Apr; 26(4):419-24. PubMed ID: 21877323
[TBL] [Abstract][Full Text] [Related]
25. A supported liquid extraction-LC-MS/MS method for determination of GDC-0980 (Apitolisib), a dual small-molecule inhibitor of class 1A phosphoinositide 3-kinase and mammalian target of rapamycin, in human plasma.
Ding X; Li F; McKnight J; Schmidt C; Strooisma K; Shimizu H; Faber K; Ware JA; Dean B
J Pharm Biomed Anal; 2014 Nov; 100():150-156. PubMed ID: 25165011
[TBL] [Abstract][Full Text] [Related]
26. [Simultaneous determination of donafenib and its N-oxide metabolite in human plasma by liquid chromatography-tandem mass spectrometry].
Wang J; Lü BH; Dai XJ; Zhang YF; Chen XY; Zhong DF
Yao Xue Xue Bao; 2017 Mar; 52(3):443-8. PubMed ID: 29979858
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous quantitation of polymyxin B1, polymyxin B2 and polymyxin B1-1 in human plasma and treated human urine using solid phase extraction and liquid chromatography-tandem mass spectrometry.
Meng M; Wang L; Liu S; Jaber OM; Gao L; Chevrette L; Reuschel S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1012-1013():23-36. PubMed ID: 26803416
[TBL] [Abstract][Full Text] [Related]
28. Quantification of FGFR4 inhibitor BLU-554 in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Dogan-Topal B; Li W; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():116-123. PubMed ID: 30802754
[TBL] [Abstract][Full Text] [Related]
29. Bioanalytical assay for the novel TRK inhibitor selitrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Sparidans RW; Li W; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1122-1123():78-82. PubMed ID: 31163324
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.
Sharma S; Dubey NK; Dasgupta AK; Sahu M; Benjamin B; Mullangi R; Srinivas NR
Biomed Chromatogr; 2012 Feb; 26(2):232-8. PubMed ID: 21594880
[TBL] [Abstract][Full Text] [Related]
31. Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates.
Sparidans RW; Li W; Schinkel AH; Schellens JHM; Beijnen JH
J Pharm Biomed Anal; 2018 Nov; 161():136-143. PubMed ID: 30149189
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the effect of plasma albumin levels on regorafenib-induced hepatotoxicity using a validated liquid chromatography-tandem mass spectrometry method.
Pang YY; Tan YL; Ho HK
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():220-224. PubMed ID: 28750235
[TBL] [Abstract][Full Text] [Related]
33. Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.
Bourget P; Amin A; Chandesris MO; Vidal F; Merlette C; Hirsch I; Cabaret L; Carvalhosa A; Mogenet A; Frenzel L; Damaj G; Lortholary O; Hermine O
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():175-81. PubMed ID: 24316764
[TBL] [Abstract][Full Text] [Related]
34. A supported liquid extraction LC-MS/MS method for determination of concentrations of GDC-0425, a small molecule Checkpoint kinase 1 inhibitor, in human plasma.
Ding X; Chen Y; Sahasranaman S; Shi Y; McKnight J; Dean B
Biomed Chromatogr; 2016 Dec; 30(12):1984-1991. PubMed ID: 27245274
[TBL] [Abstract][Full Text] [Related]
35. Validated LC-MS-MS method for the determination of quetiapine in human plasma: application to a pharmacokinetic study.
Pan RN; Kuo BP; Pao LH
J Chromatogr Sci; 2012 Mar; 50(3):277-82. PubMed ID: 22337805
[TBL] [Abstract][Full Text] [Related]
36. Quantitative bioanalytical assay for the selective RET inhibitors selpercatinib and pralsetinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Şentürk R; Wang Y; Schinkel AH; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1147():122131. PubMed ID: 32416592
[TBL] [Abstract][Full Text] [Related]
37. Quantification of the next-generation oral anti-tumor drugs dabrafenib, trametinib, vemurafenib, cobimetinib, pazopanib, regorafenib and two metabolites in human plasma by liquid chromatography-tandem mass spectrometry.
Cardoso E; Mercier T; Wagner AD; Homicsko K; Michielin O; Ellefsen-Lavoie K; Cagnon L; Diezi M; Buclin T; Widmer N; Csajka C; Decosterd L
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():124-136. PubMed ID: 29544202
[TBL] [Abstract][Full Text] [Related]
38. An LC-MS/MS method for the quantitation of cabozantinib in rat plasma: application to a pharmacokinetic study.
Su Q; Li J; Ji X; Li J; Zhou T; Lu W; Li L
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Mar; 985():119-23. PubMed ID: 25678398
[TBL] [Abstract][Full Text] [Related]
39. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.
Liu J; Yuan L; Liu G; Shen JX; Aubry AF; Arnold ME; Ji QC
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():85-91. PubMed ID: 25930207
[TBL] [Abstract][Full Text] [Related]
40. Bioanalytical assay for the quantification of the tyrosine kinase inhibitor EAI045 and its major metabolite PIA in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
Susam MM; Wang J; Schinkel AH; Beijnen JH; Sparidans RW
Biomed Chromatogr; 2022 Nov; 36(11):e5457. PubMed ID: 35855648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
